News & Publications

Solar panel
Posted: Monday, October 31, 2022
Scholars from the Center for Science, Technology and Environmental Policy (CSTEP) and the University of Texas at Austin’s LBJ School of Public Affairs recently published a paper in Energy Research & Social Science that considers why some Community Based Organizations' (CBOs) participate in the clean energy transition and analyzes how
syringe & vial
Posted: Friday, October 21, 2022
COVID-19 and its impacts have dominated the public health landscape since its emergence in late 2019.  The novel pathogen that causes COVID-19 (SARS-CoV-2) is not the only coronavirus to impact humans in recent years, and likely won’t be the last. In a commentary published in the journal Vaccine, experts from the Center for Infectious Disease Research and Policy (CIDRAP) and the Mayo Clinic discuss current coronavirus vaccine limitations, as well as the challenges of developing improved coronavirus vaccines.
DNA
Posted: Thursday, October 13, 2022
Researchers at the University of Minnesota’s BioTechnology Institute are using synthetic biology to create new forms of DNA that will eventually produce products useful to humans, such as drugs for treating disorders like stroke or Parkinson’s disease. They also aim to discover new ways to modify features of complex organisms to control the spread of disease or the destruction of fragile ecosystems. Prof.
Annals of Biomedical Engineering
Posted: Thursday, October 6, 2022
Currently, there is a shortage of viable human livers for transplantation, and thousands of potentially available organs go unused each year, as livers can only be preserved for only a short time. The NSF-funded Engineering Research Center for Advanced Technologies for the Preservation of Biological Systems (ATP-BioSM) is developing new cryopreservation technologies to extend preservation times for biological material.
Kidney Illustration
Posted: Thursday, September 29, 2022
The National Institutes of Health has awarded $2.5 million to the University of Minnesota to fund the “Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & Ethics (Minn-KPMP)." Minn-KPMP will be a recruitment site for the Kidney Precision Medicine Project (KPMP), a coalition of leading research teams using precision medicine to deve
NetEthics
Posted: Wednesday, September 21, 2022
The National Science Foundation (NSF) has funded a groundbreaking 2-year project on NetEthics: Building Tools & Training to Advance Responsible Conduct in Complex Research Networks Pioneering Novel Technologies. The project team is led by Consortium Chair Susan Wolf and includes Profs.
WaterResourcesConference
Posted: Wednesday, September 7, 2022
Registration is now open for the 2022 Minnesota Water Resources Conference, which will be held in-person October 18-19 in St. Paul. The conference will feature plenary sessions on climate change adaptation and the future of the Minnesota Clean Water Fund; presentations on wetlands, agriculture, stormwater and nutrients in surface waters will also be offered. In addition, the inaugural Deborah L.
COVID vaccine
Posted: Friday, September 2, 2022
While a new COVID vaccine booster to provide improved protection against Omicron variants has now received FDA authorization and CDC approval, experts warn that access to vaccine boosters is worsening. In a recent New York Times article, Prof.
Dr. Judy Illes
Posted: Thursday, August 25, 2022
Judy Illes, CM, PhD, FRSC, FCAHS, was recently presented the Alvin J. Thompson award in recognition of her partnership with the Tahltan, a First Nations people living in what is now considered British Columbia, Canada. Their program is recognized for being a "genuine research partnership between academic researchers and a First Nations community, which brought together knowledge and expertise to advance research and wellness." The Northwest Association of Biomedical Research (NWABR) learned of Dr.
COVID
Posted: Tuesday, August 16, 2022
Professor of Neurosurgery and Stem Cell Institute faculty member Walter Low, PhD, is among a group of researchers who were recently awarded a five-year grant by the National Institutes of Health to study the potential impact of SARS-CoV2 infection on cognitive function, especially in people at risk for Alzheimer’s disease. Individuals with a particular gene variant, APOE4, are more vulnerable to both long-COVID and Alzheimer’s disease. Some Alzheimer’s researchers also hypothesize that Alzheimer's may be triggered by a latent viral component.